abagovomab 39
abciximab 33
abituzumab 23
abrilumab 23
actoxumab 19
adalimumab 22
aducanumab 15
afasevikumab 21
alacizumab_pegol 15
alemtuzumab 30
alirocumab 27
amatuximab 46
andecaliximab 25
anifrolumab 23
anrukinzumab 24
aprutumab 22
aprutumab_ixadotin 22
arcitumomab 27
ascrinvacumab 11
atezolizumab 17
atinumab 17
avelumab 16
basiliximab 38
bavituximab 44
begelomab 33
benralizumab 31
bevacizumab_beta 26
bezlotoxumab 19
bimagrumab 20
bleselumab 22
blinatumomab 41
blosozumab 34
bococizumab 21
brazikumab 18
brentuximab_vedotin 39
briakinumab 20
brodalumab 18
brolucizumab 30
brontictuzumab 29
burosumab 22
cabiralizumab 29
camrelizumab 16
canakinumab 28
cantuzumab_ravtansin 48
carlumab 18
carotuximab 31
cergutuzumab_amunaleukin2 30
cergutuzumab_amunaleukin 30
certolizumab_pegol 26
cetiximab 49
citatuzumab_bogatox 29
cixutumumab 33
clivatuzumab_tetraxetan 27
codrituzumab 34
conatumumab 17
concizumab 33
crenezumab 25
crizanlizumab 29
crotedumab 23
dacetuzumab 25
daclizumab 22
dalotuzumab 39
dapirolizumab_pegol 28
daratumumab 14
dectrekumab 11
demcizumab 30
denosumab 11
depatuxizumab 26
depatuxizumab_mafodotin 26
dezamizumab 26
dinutuximab 41
diridavumab 32
domagrozumab 18
drozitumab 24
duligotuzumab 21
durvalumab 14
dusigitumab 26
efalizumab 35
efungumab 34
eldelumab 18
elezanumab 24
elgemtumab 14
elotuzumab 20
emactuzumab 23
emapalumab 27
emibetuzumab 25
enavatuzumab 26
enfortumab_vedotin 15
enoblituzumab 20
enokizumab 27
enoticumab 20
ensituximab 41
eptinezumab 20
erenumab 28
etaracizumab 18
etrolizumab 24
evinacumab 23
evolocumab 23
farletuzumab 16
fasinumab 26
fezakinumab 25
fibatuzumab 18
ficlatuzumab 28
firivumab 37
flanvotumab 21
fletikumab 30
foralumab 16
foravirumab 16
fremanezumab 31
fresolimumab 19
fulranumab 24
futuximab 37
galcanezumab 25
ganitumab 29
gantenerumab 15
gemetuzumab 34
gemtuzumab2 28
gemtuzumab 33
gevokizumab 27
girentuximab 37
glembatumumab 22
glembatumumab_vedotin 22
guselkumab 27
ibalizumab 32
ibritumomab 42
icrucumab 13
idarucizumab 42
ifabotuzumab 18
imalumab 19
imgatuzumab 24
inclacumab 21
indatuximab_ravtansin 40
indusatumab 22
inebilizumab 34
intetumumab 18
iodine_girentuximab 31
ipilimumab 7
iratumumab 16
isatuximab 41
itolizumab 30
ixekizumab 37
labetuzumab_govitecan 30
lambrolizumab 30
lampalizumab 31
lanadelumab 19
landogrozumab 19
laprituximab 31
lebrikizumab 40
lendalizumab 27
lenzilumab 20
lifastuzumab_vedotin 26
ligelizumab 25
lilotomab 46
lirilumab 25
lodelcizumab 21
lokivetmab 28
lorvotuzumab_mertansin 29
lucatumumab 30
lumretuzumab 24
lupartumab 21
lutikizumab 23
margetuximab 40
milatuzumab 44
mirvetuximab 42
mirvetuximab_soravtansin 42
modotuximab 44
mogamulizumab 36
monalizumab 23
motavizumab 38
moxetumomab_pasudotox 34
namilumab 27
naratuximab 33
naratuximab_emtansin 33
narnatumab 20
navicixizumab2 32
navicixizumab 31
navivumab 41
necitumumab 12
nemolizumab 32
nesvacumab 18
nivolumab 15
obiltoxaximab 27
obinutuzumab 39
ocaratuzumab 28
ofatumumab 20
olaratumab 20
olokizumab 29
omalizumab 20
onartuzumab 24
ontuxizumab 35
opicinumab 15
orticumab 16
otelixizumab 41
oxelumab 14
ozanezumab 36
pamrevlumab 13
panobacumab 32
parsatuzumab 30
pasotuxizumab 23
pateclizumab 21
patritumab 27
pembrolizumab 30
perakizumab 25
pidilizumab 22
pinatuzumab_vedotin 19
plozalizumab 37
pogalizumab 25
polatuzumab_vedotin 24
ponezumab 41
prezalumab 16
pritoxaximab 45
quilizumab 23
racotumomab 37
radretumab 16
ralpancizumab 25
ramucirumab 14
ranevetmab 33
ranibizumab 26
refanezumab 30
remtolumab 22
rilotumumab 23
rinucumab 21
risankizumab 38
rituximab 29
rivabazumab 24
robatumumab 20
roledumab 37
romosozumab 26
rontalizumab 24
rosmantuzumab 30
rozanolixizumab 25
sacituzumab 34
sacituzumab_govitecan 34
samalizumab 30
sapelizumab 28
sarilumab 19
secukinumab 19
seribantumab 18
setoxaximab 50
sifalimumab 16
siltuximab 27
simtuzumab 30
sirukumab 15
solanezumab 27
solitomab 36
stamulumab 23
suptavumab 28
suvizumab 25
tabalumab 17
tadocizumab 21
tamtuvetmab 37
tanezumab 24
tarextumab 13
tavolixizumab 19
telisotuzumab 33
teplizumab 26
tesidolumab 24
tezepelumab 27
tigatuzumab 18
tildrakizumab 26
timolumab 17
tisotumab 16
tosatoxumab 45
tositumomab 41
tralokinumab 33
trastuzumab 25
tregalizumab 34
trevogrumab 16
ublituximab 36
urelumab 21
ustekinumab 29
utomilumab 29
vadastuximab 29
vadastuximab_talirin 29
vandortuzumab_vedotin 22
vantictumab 22
vanucizumab2 26
vanucizumab 34
varlilumab 18
vatelizumab 22
vedolizumab 32
veltuzumab 22
vesencumab 13
vorsetuzumab 29
vorsetuzumab_mafodotin 29
vunakizumab 38
xentuzumab 20
zatuximab 44
